By proceeding, you agree to our Terms of Use and Privacy Policy.
Amador Bioscience is a Translational & Clinical CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to biopharmaceutical companies in China, USA and EU. Amador is committed to facilitating innovative drug development from discovery to clinical development and global regulatory fillings. Since its inception in 2018, Amador Bioscience has actively supported 80+ clinical projects, multiple IND and 6 CTD filings in USA and China. Our clients range from cutting-edge biotech startups to industry-leading multinationals.
02-02 October 2023
Many of the exciting advances in drug discovery and development today concern the immune response and its manipulation and control. Our understanding of immune involvement in therapeutic disorders and their treatment is developing rapidly. T and B ly
Event Ended
Hybrid
Paid
Washington, DC
02-05 October 2023
CHI is excited to host its 15th Annual Immunogenicity & Bioassay Summit in Washington, D.C. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from the industry, academia and the regulatory
03-04 October 2023
This year's Immunogenicity Summit brings the FDA together with leading industry and academic experts to discuss the development, application and validation of immunogenicity assays. Learn how to manage drug and target interference and tolerance, unde
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
USA
San Diego